Difference between revisions of "Steroid conversions"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "3 PubMed]" to "3/ PubMed]") |
||
(9 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | {| class="wikitable sortable" border="1" | + | {| class="wikitable sortable" border="1" style="text-align:center;" |
!Steroid | !Steroid | ||
− | !Equivalent dose (mg) | + | !Equivalent (glucocorticoid) dose (mg) |
!Half-life (hours), biologic | !Half-life (hours), biologic | ||
!Relative anti-inflammatory (glucocorticoid) potency | !Relative anti-inflammatory (glucocorticoid) potency | ||
Line 12: | Line 12: | ||
|0.8 | |0.8 | ||
|- | |- | ||
− | |align="left" | Hydrocortisone | + | |align="left" | [[Hydrocortisone (Cortef)]] |
|20 | |20 | ||
|8-12 | |8-12 | ||
Line 18: | Line 18: | ||
|1 | |1 | ||
|- | |- | ||
− | |align="left" | Prednisone | + | |align="left" | [[Prednisone (Sterapred)]] |
|5 | |5 | ||
|18-36 | |18-36 | ||
Line 24: | Line 24: | ||
|0.8 | |0.8 | ||
|- | |- | ||
− | |align="left" | Prednisolone | + | |align="left" | [[Prednisolone (Millipred)]] |
|5 | |5 | ||
|18-36 | |18-36 | ||
Line 30: | Line 30: | ||
|0.8 | |0.8 | ||
|- | |- | ||
− | |align="left" | Methylprednisolone ( | + | |align="left" | [[Methylprednisolone (Solumedrol)]] |
|4 | |4 | ||
|18-36 | |18-36 | ||
Line 36: | Line 36: | ||
|0.5 | |0.5 | ||
|- | |- | ||
− | |align="left" | Dexamethasone (Decadron) | + | |align="left" | [[Dexamethasone (Decadron)]] |
|0.75 | |0.75 | ||
|36-54 | |36-54 | ||
Line 45: | Line 45: | ||
==References== | ==References== | ||
− | # Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. [ | + | # Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. [https://pubmed.ncbi.nlm.nih.gov/888843/ PubMed] |
+ | |||
+ | [[Category:General reference pages]] | ||
+ | [[Category:Clinical pharmacology]] |
Latest revision as of 23:27, 26 April 2023
Steroid | Equivalent (glucocorticoid) dose (mg) | Half-life (hours), biologic | Relative anti-inflammatory (glucocorticoid) potency | Relative mineralocorticoid (Na+ retaining) potency |
---|---|---|---|---|
Cortisone | 25 | 8-12 | 0.8 | 0.8 |
Hydrocortisone (Cortef) | 20 | 8-12 | 1 | 1 |
Prednisone (Sterapred) | 5 | 18-36 | 4 | 0.8 |
Prednisolone (Millipred) | 5 | 18-36 | 4 | 0.8 |
Methylprednisolone (Solumedrol) | 4 | 18-36 | 5 | 0.5 |
Dexamethasone (Decadron) | 0.75 | 36-54 | 25 | 0 |
References
- Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977 Aug;63(2):200-7. PubMed